https://www.selleckchem.com/pr....oducts/liraglutide.h
OBJECTIVE To assess the association of public health parameters with the regional variation in the initial treatment for prostate cancer. METHODS We used data from German epidemiologic cancer registries for the years 2009-2013. Presence of a certified cancer center, a radiotherapy and/or urology institution, the district-specific GDP, and population density were used as predictors. Patients with indication for adjuvant treatment were excluded (T3b). Only districts with defined quality criteria were eligible. We used general linear m
Gefällt mir
Kommentar
Teilen
